Population-based studies of antithyroid drugs and sudden cardiac death

British Journal of Clinical Pharmacology

Volumn 68, Issue 3, 2009, Pages 447-454

  Van Noord, Charlotte ^a,d   Sturkenboom, Miriam C J M ^a,c   Straus, Sabine M J M ^a,d   Hofman, Albert ^a   Witteman, Jacqueline C M ^a   Stricker, Bruno H Ch ^a,b,e  

^a GENERAL ELECTRIC COMPANY   (United States)

^b Sint Franciscus Gasthuis   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d MEDICINES EVALUATION BOARD   (Netherlands)

^e Inspectorate for Health Care   (Netherlands)

Author keywords

Antithyroid drugs; Hyperthyroidism; Sudden cardiac death

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; NONDIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER; THYROID HORMONE; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN ISCHEMIA; COMORBIDITY; CONTROLLED STUDY; FEMALE; GENERAL PRACTICE; HEART ARRHYTHMIA; HEART DEATH; HORMONE DETERMINATION; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QT PROLONGATION; RISK FACTOR; SEX RATIO; SUDDEN DEATH;

AGED; AGED, 80 AND OVER; ANTITHYROID AGENTS; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 69949124293     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03474.x     Document Type: Article

References (44)

1. Campbell AJ, Reinken J, Allan BC. Thyroid disease in the elderly in the community. Age Ageing 1981 10 : 47 52.
2. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991 34 : 77 83.
3. Diez JJ. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management. Gerontology 2003 49 : 316 323.
4. Gambert SR. Hyperthyroidism in the elderly. Clin Geriatr Med 1995 11 : 181 188.
5. Colzani RM, Emdin M, Conforti F, Passino C, Scarlattini M, Iervasi G. Hyperthyroidism is associated with lengthening of ventricular repolarization. Clin Endocrinol (Oxf) 2001 55 : 27 32.
6. Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation 1993 87 : 1435 1441.
7. van Noord C, van der Deure W, Sturkenboom M, Straus S, Hofman A, Visser T, Kors J, Witteman J, Stricker B. High free T4 levels are associated with QTc prolongation in males. J Endocrinol 2008 198 : 253 260.
8. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002 287 : 2215 2220.
9. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004 350 : 1013 1022.
10. Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA 2003 289 : 2120 2127.
11. Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003 89 : 1363 1372.
12. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, Deckers JW, Kingma JH, Sturkenboom MC, Stricker BH, Witteman JC. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006 47 : 362 367.
13. Fox CS, Evans JC, Larson MG, Kannel WB, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation 2004 110 : 522 527.
14. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001 358 : 861 865.
15. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002 137 : 904 914.
16. Flynn RW, Macdonald TM, Jung RT, Morris AD, Leese GP. Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab 2006 91 : 2159 2164.
17. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 2005 165 : 2467 2472.
18. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006 295 : 1033 1041.
19. Sarma JS, Venkataraman K, Nicod P, Polikar R, Smith J, Schoenbaum MP, Singh BN. Circadian rhythmicity of rate-normalized QT interval in hypothyroidism and its significance for development of class III antiarrhythmic agents. Am J Cardiol 1990 66 : 959 963.
20. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, Rodondi N. Meta-analysis subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 2008 148 : 832 845.
21. Fisher J. Thyrotoxic periodic paralysis with ventricular fibrillation. Arch Intern Med 1982 142 : 1362 1364.
22. Carey D, Hurst JW Jr., Silverman ME. Coronary spasm and cardiac arrest after coronary arteriography in unsuspected thyrotoxicosis. Am J Cardiol 1992 70 : 833 834.
23. Ohshima T, Maeda H, Takayasu T, Fujioka Y, Nakaya T, Saito K, Nagano T An autopsy case of sudden death due to hyperthyroidism Nihon Hoigaku Zasshi 1990 44 : 365 370.
24. Terndrup TE, Heisig DG, Garceau JP. Sudden death associated with undiagnosed Graves' disease. J Emerg Med 1990 8 : 553 555.
25. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991 7 : 403 422.
26. Hofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, Stricker BH, Tiemeier H, Uitterlinden AG, Vingerling JR, Witteman JC. The Rotterdam Study: objectives and design update. Eur J Epidemiol 2007 22 : 819 829.
27. Vlug AE, van der Lei J, Mosseveld BM, van Wijk MA, van der Linden PD, Sturkenboom MC, van Bemmel JH. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med 1999 38 : 339 344.
28. van der Lei J, Duisterhout JS, Westerhof HP, van der Does E, Cromme PV, Boon WM, van Bemmel JH. The introduction of computer-based patient records in The Netherlands. Ann Intern Med 1993 119 : 1036 1041.
29. Lamberts H, Wood M, Hofmans-Okkes IM. International primary care classifications: the effect of fifteen years of evolution. Fam Pract 1992 9 : 330 339.
30. Myerburg RJ, Castellanos A. Language and interpretation of clinical trial outcomes: alternates, surrogates, and composites. Heart Rhythm 2004 1 : 538 539.
31. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm AJ, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P, Wellens HJ, Zipes DP. Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 2001 22 : 1374 1450.
32. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2009. 2008. Available at http://www.whocc.no/atcddd/ (last accessed 1 July 2009).
33. Diabetes Mellitus. Technical Reports Series 894. Geneva : World Health Organisation, 1985.
34. WHO. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999 17 : 151 183.
35. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997 96 : 1432 1437.
36. Vliegenthart R, Oudkerk M, Song B, van der Kuip DA, Hofman A, Witteman JC. Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study. Eur Heart J 2002 23 : 1596 1603. (Pubitemid 35221564)
37. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study. Eur Heart J 2004 25 : 1614 1619.
38. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A, Grobbee DE. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 1999 20 : 447 455.
39. Expert Panel on Detection EaToHBCiA. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 2497.
40. Woosley RL. Drugs that prolong the QTc interval and/ or induce Torsade de Pointes. Available at http://www.azcert.org/medical-pros/drug-lists/drug-lists. cfm (last accessed 1 July 2009).
41. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989 79 : 340 349.
42. O'Sullivan AJ, Lewis M, Diamond T. Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. Eur J Endocrinol 2006 154 : 533 536.
43. Shirani J, Barron MM, Pierre-Louis ML, Roberts WC. Congestive heart failure, dilated cardiac ventricles, and sudden death in hyperthyroidism. Am J Cardiol 1993 72 : 365 368.
44. Chugh SS, Jui J, Gunson K, Stecker EC, John BT, Thompson B, Ilias N, Vickers C, Dogra V, Daya M, Kron J, Zheng ZJ, Mensah G, McAnulty J. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 2004 44 : 1268 1275.